{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:54:18Z","timestamp":1790873658662,"version":"4.1.0"},"reference-count":196,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31730030"],"award-info":[{"award-number":["31730030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81941011"],"award-info":[{"award-number":["81941011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271403"],"award-info":[{"award-number":["82271403"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31971279"],"award-info":[{"award-number":["31971279"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272171"],"award-info":[{"award-number":["82272171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.trsl.2026.08.005","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:24:21Z","timestamp":1787066661000},"page":"17-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Regenerative medicine for neurodegenerative diseases: history, strategies, and clinical advances"],"prefix":"10.1016","volume":"297","author":[{"given":"Jia","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.trsl.2026.08.005_bib0001","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s13346-025-01887-9","article-title":"Crossing the blood-brain barrier: nanoparticle-based strategies for neurodegenerative disease therapy","volume":"16","author":"Haro-Martinez","year":"2026","journal-title":"Drug Deliv Transl Res"},{"issue":"46","key":"10.1016\/j.trsl.2026.08.005_bib0002","doi-asserted-by":"crossref","first-page":"63172","DOI":"10.1021\/acsami.5c18039","article-title":"Development of nanostructured electrode interfaces to direct neurogenesis in neurospheres","volume":"17","author":"Uchayash","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.005_bib0003","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.trsl.2026.08.005_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102205","article-title":"Harnessing two-dimensional nanomaterials for diagnosis and therapy in neurodegenerative diseases: advances, challenges and prospects","volume":"94","author":"Beura","year":"2024","journal-title":"Ageing Res Rev"},{"issue":"Pt B","key":"10.1016\/j.trsl.2026.08.005_bib0005","article-title":"Integrative computational and experimental evaluation of retinoic acid role in promoting Wharton's jelly-derived mesenchymal stem cells differentiation into neuronal cells","volume":"198","author":"Ranjan","year":"2025","journal-title":"Comput Biol Med"},{"issue":"9","key":"10.1016\/j.trsl.2026.08.005_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/cells13090779","article-title":"Mesenchymal stem cells and their role in neurodegenerative diseases","volume":"13","author":"Mattei","year":"2024","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.trsl.2026.08.005_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093103","article-title":"Neural stem cell transplantation for neurodegenerative diseases","volume":"21","author":"De Gioia","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2026.08.005_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115525","article-title":"Clinical perspective on pluripotent stem cells derived cell therapies for the treatment of neurodegenerative diseases","volume":"218","author":"Izrael","year":"2025","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0009","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13287-025-04285-7","article-title":"Cell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases","volume":"16","author":"Deng","year":"2025","journal-title":"Stem Cell Res Ther"},{"issue":"6647","key":"10.1016\/j.trsl.2026.08.005_bib0010","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1126\/science.add6492","article-title":"Emerging frontiers in regenerative medicine","volume":"380","author":"Mckinley","year":"2023","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0011","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/prd.12561","article-title":"Understanding exosomes: part 2-emerging leaders in regenerative medicine","volume":"94","author":"Miron","year":"2024","journal-title":"Periodontol 2000"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.005_bib0012","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4103\/1673-5374.324827","article-title":"From regenerative strategies to pharmacological approaches: can we fine-tune treatment for Parkinson's disease?","volume":"17","author":"Silva","year":"2022","journal-title":"Neural Regen Res"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0013","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12929-023-00939-x","article-title":"Self-healing hydrogel as an injectable implant: translation in brain diseases","volume":"30","author":"Xu","year":"2023","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.trsl.2026.08.005_bib0014","first-page":"301","article-title":"Concepts and classification of neurodegenerative diseases","volume":"145","author":"Kovacs","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.trsl.2026.08.005_bib0015","article-title":"Medial entorhinal-hippocampal desynchronization parallels the emergence of memory impairment in a mouse model of Alzheimer's disease pathology","author":"Vetere","year":"2025","journal-title":"BioRxiv"},{"issue":"42","key":"10.1016\/j.trsl.2026.08.005_bib0016","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2510287122","article-title":"Parkinsonism disrupts the balance between excitatory and inhibitory activity within the primary motor cortex during movement","volume":"122","author":"Mohanty","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.005_bib0017","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/ana.26871","article-title":"Alterations of cortical structure and neurophysiology in Parkinson's disease are aligned with neurochemical systems","volume":"95","author":"Wiesman","year":"2024","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0018","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4103\/NRR.NRR-D-23-01904","article-title":"Multifaceted superoxide dismutase 1 expression in amyotrophic lateral sclerosis patients: a rare occurrence?","volume":"20","author":"Martinelli","year":"2025","journal-title":"Neural Regen Res"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.005_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031851","article-title":"A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics","volume":"23","author":"Lamptey","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.trsl.2026.08.005_bib0020","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"Van Dyck","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.trsl.2026.08.005_bib0022","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.005_bib0023","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10561-022-10062-0","article-title":"Regenerative medicine improve neurodegenerative diseases","volume":"24","author":"Ashraf","year":"2023","journal-title":"Cell Tissue Bank"},{"key":"10.1016\/j.trsl.2026.08.005_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148688","article-title":"Recent approaches in regenerative medicine in the fight against neurodegenerative disease","volume":"1825","author":"Esmaeili","year":"2024","journal-title":"Brain Res"},{"key":"10.1016\/j.trsl.2026.08.005_bib0025","first-page":"366","article-title":"Biomaterials for stem cell engineering and biomanufacturing","volume":"4","author":"Xu","year":"2019","journal-title":"Bioact Mater"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.005_bib0026","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1353\/pbm.2000.0006","article-title":"In search of Alexander A. Maximow: the man behind the unitarian theory of hematopoiesis","volume":"43","author":"Konstantinov","year":"2000","journal-title":"Perspect Biol Med"},{"issue":"11","key":"10.1016\/j.trsl.2026.08.005_bib0027","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM195709122571102","article-title":"Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy","volume":"257","author":"Thomas","year":"1957","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2026.08.005_bib0028","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/197452a0","article-title":"Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells","volume":"197","author":"Becker","year":"1963","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.005_bib0029","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","article-title":"Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues","volume":"6","author":"Friedenstein","year":"1968","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.005_bib0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jor.1100090504","article-title":"Mesenchymal stem cells","volume":"9","author":"Caplan","year":"1991","journal-title":"J Orthop Res"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0031","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-025-02313-9","article-title":"Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies","volume":"10","author":"Han","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"5819","key":"10.1016\/j.trsl.2026.08.005_bib0032","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/292154a0","article-title":"Establishment in culture of pluripotential cells from mouse embryos","volume":"292","author":"Evans","year":"1981","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.trsl.2026.08.005_bib0033","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1073\/pnas.78.12.7634","article-title":"Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells","volume":"78","author":"Martin","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.trsl.2026.08.005_bib0034","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archneur.1989.00520420033021","article-title":"Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up","volume":"46","author":"Lindvall","year":"1989","journal-title":"Arch Neurol"},{"issue":"5052","key":"10.1016\/j.trsl.2026.08.005_bib0035","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1126\/science.1553558","article-title":"Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system","volume":"255","author":"Reynolds","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.trsl.2026.08.005_bib0036","series-title":"Degeneration and Regeneration of the Nervous System","first-page":"236","author":"Cajal","year":"1928"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.005_bib0037","first-page":"32","article-title":"The future of multihospital systems","volume":"18","author":"Kaiser","year":"1992","journal-title":"Top Health Care Financ"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.005_bib0038","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2217\/rme.11.40","article-title":"Interview: commercial translation of cell-based therapies and regenerative medicine: learning by experience. Interview by Emily Culme-Seymour","volume":"6","author":"Haseltine","year":"2011","journal-title":"Regen Med"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.005_bib0039","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jmau.2015.05.002","article-title":"Regenerative medicine: historical roots and potential strategies in modern medicine","volume":"3","author":"Sampogna","year":"2015","journal-title":"J Microsc Ultrastruct"},{"issue":"July (7)","key":"10.1016\/j.trsl.2026.08.005_bib0040","first-page":"58","article-title":"William Haseltine on regenerative medicine, aging and human immortality","volume":"8","author":"Fahy","year":"2002","journal-title":"Life Ext"},{"issue":"5110","key":"10.1016\/j.trsl.2026.08.005_bib0041","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.8493529","article-title":"Tissue engineering","volume":"260","author":"Langer","year":"1993","journal-title":"Science"},{"issue":"5391","key":"10.1016\/j.trsl.2026.08.005_bib0042","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.005_bib0043","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0092-8674(02)00835-8","article-title":"Directed differentiation of embryonic stem cells into motor neurons","volume":"110","author":"Wichterle","year":"2002","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.005_bib0044","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.005_bib0045","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"5893","key":"10.1016\/j.trsl.2026.08.005_bib0046","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1158799","article-title":"Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons","volume":"321","author":"Dimos","year":"2008","journal-title":"Science"},{"issue":"7284","key":"10.1016\/j.trsl.2026.08.005_bib0047","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nature08797","article-title":"Direct conversion of fibroblasts to functional neurons by defined factors","volume":"463","author":"Vierbuchen","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.005_bib0048","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.stem.2013.12.001","article-title":"In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model","volume":"14","author":"Guo","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"9817","key":"10.1016\/j.trsl.2026.08.005_bib0049","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(12)60028-2","article-title":"Embryonic stem cell trials for macular degeneration: a preliminary report","volume":"379","author":"Schwartz","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.trsl.2026.08.005_bib0050","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","article-title":"Autologous induced stem-cell-derived retinal cells for macular degeneration","volume":"376","author":"Mandai","year":"2017","journal-title":"N Engl J Med"},{"issue":"9967","key":"10.1016\/j.trsl.2026.08.005_bib0051","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","article-title":"Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1\/2 studies","volume":"385","author":"Schwartz","year":"2015","journal-title":"Lancet"},{"issue":"8064","key":"10.1016\/j.trsl.2026.08.005_bib0052","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","article-title":"Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease","volume":"641","author":"Sawamoto","year":"2025","journal-title":"Nature"},{"issue":"8064","key":"10.1016\/j.trsl.2026.08.005_bib0053","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41586-025-08845-y","article-title":"Phase I trial of hES cell-derived dopaminergic neurons for Parkinson's disease","volume":"641","author":"Tabar","year":"2025","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.trsl.2026.08.005_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2025.09.010","article-title":"Phase 1\/2a clinical trial of hESC-derived dopamine progenitors in Parkinson's disease","volume":"188","author":"Chang","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2026.08.005_bib0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-026-04525-0","article-title":"Human embryonic stem cell-derived dopaminergic cells for Parkinson's disease: a phase 1\/2 open-label trial","author":"Paul","year":"2026","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.trsl.2026.08.005_bib0056","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a040907","article-title":"Regeneration, rejuvenation, and replacement: turning back the clock on tissue aging","volume":"13","author":"Rando","year":"2021","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.005_bib0057","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1752-8062.2008.00039.x","article-title":"Strategies for therapeutic repair: the \"R(3)\" regenerative medicine paradigm","volume":"1","author":"Nelson","year":"2008","journal-title":"Clin Transl Sci"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0058","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41392-023-01343-5","article-title":"Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases","volume":"8","author":"Ji","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"6755","key":"10.1016\/j.trsl.2026.08.005_bib0059","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.adu9575","article-title":"Identification of proliferating neural progenitors in the adult human hippocampus","volume":"389","author":"Dumitru","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.trsl.2026.08.005_bib0060","doi-asserted-by":"crossref","DOI":"10.1002\/alz70855_099238","article-title":"Quinic acid (QA) ameliorate Alzheimer's disease pathology by enhancing endogenous neurogenesis through regulating Wnt\/\u03b2-catenin pathway","volume":"21","author":"Farooq Khan","year":"2025","journal-title":"Alzheimer's Dement"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0061","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13287-024-03925-8","article-title":"DVL\/GSK3\/ISL1 pathway signaling: unraveling the mechanism of SIRT3 in neurogenesis and AD therapy","volume":"15","author":"Dai","year":"2024","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"10.1016\/j.trsl.2026.08.005_bib0062","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.3892\/or.2020.7782","article-title":"Increased hippocampal TrkA expression ameliorates cranial radiation\u2011induced neurogenesis impairment and cognitive deficit via PI3K\/AKT signaling","volume":"44","author":"Ji","year":"2020","journal-title":"Oncol Rep"},{"key":"10.1016\/j.trsl.2026.08.005_bib0063","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuropharm.2015.05.020","article-title":"Simvastatin prevents beta-amyloid(25-35)-impaired neurogenesis in hippocampal dentate gyrus through alpha7nAChR-dependent cascading PI3K-Akt and increasing BDNF via reduction of farnesyl pyrophosphate","volume":"97","author":"Wang","year":"2015","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.005_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00501","article-title":"Intranasal administration of mesenchymal stem cells overexpressing FGF21 demonstrates therapeutic potential in experimental Parkinson's disease","volume":"22","author":"Lin","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.trsl.2026.08.005_bib0065","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202510539","article-title":"Renovating neural networks with viral-mediated gene transfer from a tissue contacting matrix mimic","author":"Dehnavi","year":"2026","journal-title":"Small"},{"key":"10.1016\/j.trsl.2026.08.005_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102808","article-title":"Start the engine of neuroregeneration: a mechanistic and strategic overview of direct astrocyte-to-neuron reprogramming","volume":"110","author":"Jiang","year":"2025","journal-title":"Ageing Res Rev"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.005_bib0067","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","article-title":"Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors","volume":"142","author":"Ieda","year":"2010","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.trsl.2026.08.005_bib0068","doi-asserted-by":"crossref","first-page":"16744","DOI":"10.1021\/acsnano.5c01457","article-title":"Electromagnetized MXenes enhance the efficient direct reprogramming of dopamine neurons for Parkinson's disease therapy","volume":"19","author":"Kim","year":"2025","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.trsl.2026.08.005_bib0069","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.stem.2015.09.012","article-title":"Small molecules efficiently reprogram human astroglial cells into functional neurons","volume":"17","author":"Zhang","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.trsl.2026.08.005_bib0070","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.4103\/1673-5374.390965","article-title":"Cell reprogramming therapy for Parkinson's disease","volume":"19","author":"Dong","year":"2024","journal-title":"Neural Regen Res"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.005_bib0071","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4103\/1673-5374.353482","article-title":"In vivo astrocyte-to-neuron reprogramming for central nervous system regeneration: a narrative review","volume":"18","author":"Talifu","year":"2023","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.trsl.2026.08.005_bib0072","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semcdb.2021.05.028","article-title":"Environmental factors influence somatic cell reprogramming to cardiomyocyte-like cells","volume":"122","author":"Van Handel","year":"2022","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.trsl.2026.08.005_bib0073","doi-asserted-by":"crossref","DOI":"10.1002\/alz70855_107476","article-title":"Neuronal reprogramming improves brain health in TgAD and aging rats","volume":"21","author":"Ribeiro","year":"2025","journal-title":"Alzheimer's Dementia"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.005_bib0074","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114797","article-title":"Parkinson's disease motor symptoms rescue by CRISPRa-reprogramming astrocytes into GABAergic neurons","volume":"14","author":"Giehrl-Schwab","year":"2022","journal-title":"EMBO Mol Med"},{"issue":"7813","key":"10.1016\/j.trsl.2026.08.005_bib0075","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41586-020-2388-4","article-title":"Reversing a model of Parkinson's disease with in situ converted nigral neurons","volume":"582","author":"Qian","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.005_bib0076","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.stem.2011.09.002","article-title":"Direct lineage conversion of terminally differentiated hepatocytes to functional neurons","volume":"9","author":"Marro","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.trsl.2026.08.005_bib0077","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/s41593-022-01185-4","article-title":"Age-related Huntington's disease progression modeled in directly reprogrammed patient-derived striatal neurons highlights impaired autophagy","volume":"25","author":"Oh","year":"2022","journal-title":"Nat Neurosci"},{"issue":"9","key":"10.1016\/j.trsl.2026.08.005_bib0078","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1080\/15548627.2023.2175572","article-title":"Modeling Huntington disease through microRNA-mediated neuronal reprogramming identifies age-associated autophagy dysfunction driving the onset of neurodegeneration","volume":"19","author":"Oh","year":"2023","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0079","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/s13287-024-04057-9","article-title":"Reprogrammed human lateral ganglionic eminence precursors generate striatal neurons and restore motor function in a rat model of Huntington's disease","volume":"15","author":"Mccaughey-Chapman","year":"2024","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.005_bib0080","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.stem.2015.07.006","article-title":"Direct conversion of normal and Alzheimer's disease human fibroblasts into neuronal cells by small molecules","volume":"17","author":"Hu","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trsl.2026.08.005_bib0081","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.actbio.2026.02.055","article-title":"Cell-targeted nanocomplex facilitates direct reprogramming of astrocytes into dopaminergic neurons in Parkinson's disease","volume":"214","author":"Hwang","year":"2026","journal-title":"Acta Biomater"},{"issue":"12","key":"10.1016\/j.trsl.2026.08.005_bib0082","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028719","article-title":"Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector","volume":"6","author":"Addis","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.005_bib0083","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nbt.3835","article-title":"Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model","volume":"35","author":"Rivetti Di Val Cervo","year":"2017","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0084","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41467-020-14855-3","article-title":"Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington's disease","volume":"11","author":"Wu","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.005_bib0085","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nn828","article-title":"Glial cells generate neurons: the role of the transcription factor Pax6","volume":"5","author":"Heins","year":"2002","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0086","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ymthe.2019.09.003","article-title":"A NeuroD1 AAV-based gene therapy for functional brain repair after ischemic injury through in vivo astrocyte-to-neuron conversion","volume":"28","author":"Chen","year":"2020","journal-title":"Mol Ther"},{"issue":"25","key":"10.1016\/j.trsl.2026.08.005_bib0087","doi-asserted-by":"crossref","first-page":"9336","DOI":"10.1523\/JNEUROSCI.3975-14.2015","article-title":"Ascl1 converts dorsal midbrain astrocytes into functional neurons in vivo","volume":"35","author":"Liu","year":"2015","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.005_bib0088","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000373","article-title":"Directing astroglia from the cerebral cortex into subtype specific functional neurons","volume":"8","author":"Heinrich","year":"2010","journal-title":"PLoS Biol"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.005_bib0089","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.stemcr.2016.09.013","article-title":"Small molecules modulate chromatin accessibility to promote NEUROG2-mediated fibroblast-to-neuron reprogramming","volume":"7","author":"Smith","year":"2016","journal-title":"Stem Cell Rep"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.005_bib0090","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s44321-025-00209-3","article-title":"AAV-mediated expression of proneural factors stimulates neurogenesis from adult Muller glia in vivo","volume":"17","author":"Pavlou","year":"2025","journal-title":"EMBO Mol Med"},{"issue":"6","key":"10.1016\/j.trsl.2026.08.005_bib0091","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.stem.2012.05.005","article-title":"Induced pluripotent stem cells: past, present, and future","volume":"10","author":"Yamanaka","year":"2012","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.trsl.2026.08.005_bib0092","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17091494","article-title":"Advances and future applications of augmented peripheral nerve regeneration","volume":"17","author":"Jones","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.005_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2025.01.006","article-title":"Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson's disease","volume":"32","author":"Jeon","year":"2025","journal-title":"Cell Stem Cell"},{"issue":"8","key":"10.1016\/j.trsl.2026.08.005_bib0094","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041611","article-title":"Dopamine cell-based replacement therapies","volume":"15","author":"Kayhanian","year":"2025","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.005_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00436","article-title":"Bioreactor-produced iPSCs-derived dopaminergic neuron-containing neural microtissues innervate and normalize rotational bias in a dose-dependent manner in a Parkinson rat model","volume":"21","author":"Prudon","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"8104","key":"10.1016\/j.trsl.2026.08.005_bib0096","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/d41586-026-00585-x","article-title":"First-of-a-kind stem-cell therapies set for approval in Japan","volume":"651","author":"Mullard","year":"2026","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.trsl.2026.08.005_bib0097","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/brain\/awae026","article-title":"The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson's disease","volume":"147","author":"Bjorklund","year":"2024","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.005_bib0098","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041295","article-title":"Considerations for developing an autologous induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) replacement therapy","volume":"14","author":"Bose","year":"2024","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"20","key":"10.1016\/j.trsl.2026.08.005_bib0099","doi-asserted-by":"crossref","DOI":"10.3390\/cells11203241","article-title":"Ex vivo integration of human stem retinal ganglion cells into the mouse retina","volume":"11","author":"Croteau","year":"2022","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.trsl.2026.08.005_bib0100","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202414890","article-title":"Unraveling neurodevelopment: synergistic effects of intrinsic genetic programs and extrinsic environmental cues","volume":"12","author":"Wang","year":"2025","journal-title":"Adv Sci"},{"issue":"12","key":"10.1016\/j.trsl.2026.08.005_bib0101","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.4103\/NRR.NRR-D-23-01775","article-title":"A core scientific problem in the treatment of central nervous system diseases: newborn neurons","volume":"19","author":"Hao","year":"2024","journal-title":"Neural Regen Res"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41420-025-02906-x","article-title":"Melatonin orchestrates mitochondrial fusion dynamics-mediated WNT\/beta-catenin signaling to promote dopaminergic neuronal differentiation of human iPS and nerve regeneration in a MPTP-induced mouse model of Parkinson's disease","volume":"12","author":"Zhang","year":"2025","journal-title":"Cell Death Discov"},{"issue":"8","key":"10.1016\/j.trsl.2026.08.005_bib0103","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00018-023-04882-w","article-title":"Soluble mutant huntingtin drives early human pathogenesis in Huntington's disease","volume":"80","author":"Miguez","year":"2023","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"10.1016\/j.trsl.2026.08.005_bib0104","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081992","article-title":"Stem cells: innovative therapeutic options for neurodegenerative diseases?","volume":"10","author":"Bonaventura","year":"2021","journal-title":"Cells"},{"issue":"23","key":"10.1016\/j.trsl.2026.08.005_bib0105","doi-asserted-by":"crossref","DOI":"10.3390\/cells12232711","article-title":"Repeated intravenous administration of human neural stem cells producing choline acetyltransferase exerts anti-aging effects in male F344 rats","volume":"12","author":"Kyung","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.trsl.2026.08.005_bib0106","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jchemneu.2019.01.003","article-title":"Differentiation of human mesenchymal stem cells (MSC) to dopaminergic neurons: a comparison between Wharton's jelly and olfactory mucosa as sources of MSCs","volume":"96","author":"Alizadeh","year":"2019","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.trsl.2026.08.005_bib0107","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120448","article-title":"MSC spheroids-loaded collagen hydrogels simultaneously promote neuronal differentiation and suppress inflammatory reaction through PI3K-Akt signaling pathway","volume":"265","author":"He","year":"2021","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0108","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4062\/biomolther.2019.065","article-title":"Differentiation of human mesenchymal stem cells towards neuronal lineage: clinical trials in nervous system disorders","volume":"28","author":"Hernandez","year":"2020","journal-title":"Biomol Ther"},{"issue":"12","key":"10.1016\/j.trsl.2026.08.005_bib0109","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.4103\/1673-5374.313026","article-title":"Potential effects of mesenchymal stem cell derived extracellular vesicles and exosomal miRNAs in neurological disorders","volume":"16","author":"Nakano","year":"2021","journal-title":"Neural Regen Res"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s11658-022-00359-z","article-title":"Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects","volume":"27","author":"Rahbaran","year":"2022","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.trsl.2026.08.005_bib0111","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120108","article-title":"A biocompatible and injectable hydrogel to boost the efficacy of stem cells in neurodegenerative diseases treatment","volume":"287","author":"Ferreira","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.trsl.2026.08.005_bib0112","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2147\/IJN.S395010","article-title":"Nanotherapeutic and stem cell therapeutic strategies in neurodegenerative diseases: a promising therapeutic approach","volume":"18","author":"Wei","year":"2023","journal-title":"Int J Nanomedicine"},{"issue":"14","key":"10.1016\/j.trsl.2026.08.005_bib0113","article-title":"Regulation of neural differentiation of ADMSCs using graphene-mediated wireless-localized electrical signals driven by electromagnetic induction","volume":"9","author":"Guo","year":"2022","journal-title":"Adv Sci"},{"key":"10.1016\/j.trsl.2026.08.005_bib0114","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121566","article-title":"Therapeutic application of mesenchymal stem cells derived exosomes in neurodegenerative diseases: a focus on non-coding RNAs cargo, drug delivery potential, perspective","volume":"320","author":"Hedayat","year":"2023","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13287-025-04160-5","article-title":"Mesenchymal stem cell exosome therapy: current research status in the treatment of neurodegenerative diseases and the possibility of reversing normal brain aging","volume":"16","author":"Quan","year":"2025","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0116","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s43587-023-00539-2","article-title":"Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming","volume":"4","author":"Cipriano","year":"2024","journal-title":"Nat Aging"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0117","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s12967-025-06472-9","article-title":"Therapeutic implications of mitochondrial transfer on stem cell fate in regenerative medicine","volume":"23","author":"Liu","year":"2025","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0118","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13538","article-title":"Emerging rejuvenation strategies-reducing the biological age","volume":"21","author":"Zhang","year":"2022","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.005_bib0119","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s43587-022-00183-2","article-title":"In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice","volume":"2","author":"Browder","year":"2022","journal-title":"Nat Aging"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.stem.2025.12.011","article-title":"Anti-aging strategies and ex vivo organ rejuvenation","volume":"33","author":"Haoui","year":"2026","journal-title":"Cell Stem Cell"},{"issue":"21","key":"10.1016\/j.trsl.2026.08.005_bib0121","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2025.07.031","article-title":"Prevalent mesenchymal drift in aging and disease is reversed by partial reprogramming","volume":"188","author":"Lu","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2026.08.005_bib0122","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2025.102743","article-title":"Partial reprogramming by cyclical overexpression of Yamanaka factors improves pathological phenotypes of tauopathy mouse model of human Alzheimer's disease","volume":"247","author":"Anton-Fernandez","year":"2025","journal-title":"Prog Neurobiol"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.005_bib0123","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s43587-024-00594-3","article-title":"Restoration of neuronal progenitors by partial reprogramming in the aged neurogenic niche","volume":"4","author":"Xu","year":"2024","journal-title":"Nat Aging"},{"key":"10.1016\/j.trsl.2026.08.005_bib0124","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2025.11.028","article-title":"Cognitive rejuvenation through partial reprogramming of engram cells","author":"Berdugo-Vega","year":"2026","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.005_bib0125","doi-asserted-by":"crossref","DOI":"10.1111\/acel.70390","article-title":"In vivo chemical reprogramming is associated with a toxic accumulation of lipid droplets hindering rejuvenation","volume":"25","author":"Mitchell","year":"2026","journal-title":"Aging Cell"},{"key":"10.1016\/j.trsl.2026.08.005_bib0126","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2026.103009","article-title":"The epigenetic rejuvenation promise: partial reprogramming as a therapeutic strategy for aging and disease","volume":"115","author":"Li","year":"2026","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0127","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s42003-024-06328-w","article-title":"In vivo cyclic overexpression of Yamanaka factors restricted to neurons reverses age-associated phenotypes and enhances memory performance","volume":"7","author":"Anton-Fernandez","year":"2024","journal-title":"Commun Biol"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.005_bib0128","doi-asserted-by":"crossref","DOI":"10.3390\/cells13040343","article-title":"In vivo reprogramming using Yamanaka factors in the CNS: a scoping review","volume":"13","author":"Cho","year":"2024","journal-title":"Cells"},{"issue":"8022","key":"10.1016\/j.trsl.2026.08.005_bib0129","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41586-024-07680-x","article-title":"CryoET of beta-amyloid and tau within postmortem Alzheimer's disease brain","volume":"631","author":"Gilbert","year":"2024","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.005_bib0130","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/15548627.2022.2071081","article-title":"Hitchhiker's guide through the axon: transport and local translation of Pink1 mRNA support axonal mitophagy","volume":"18","author":"Metur","year":"2022","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0131","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40035-025-00525-1","article-title":"LRRK2 G2019S mutation contributes to mitochondrial transfer dysfunction in a Drp1-STX17-dependent manner","volume":"14","author":"Ding","year":"2025","journal-title":"Transl Neurodegener"},{"issue":"7","key":"10.1016\/j.trsl.2026.08.005_bib0132","doi-asserted-by":"crossref","DOI":"10.3390\/cells12071006","article-title":"The beneficial effect of mitochondrial transfer therapy in 5XFAD mice via liver-serum-brain response","volume":"12","author":"Sweetat","year":"2023","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.005_bib0133","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00355","article-title":"Mitochondrial transplantation exhibits neuroprotective effects and improves behavioral deficits in an animal model of Parkinson's disease","volume":"21","author":"Eo","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"43","key":"10.1016\/j.trsl.2026.08.005_bib0134","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2505237122","article-title":"Nanomaterial-induced mitochondrial biogenesis enhances intercellular mitochondrial transfer efficiency","volume":"122","author":"Soukar","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2026.08.005_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123747","article-title":"Nanomaterial-based strategies for anti-aging and regeneration in oral and maxillofacial tissues: mechanisms and applications","volume":"327","author":"Cai","year":"2026","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.005_bib0136","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5580","article-title":"Lipid metabolism in microglia: emerging mechanisms and therapeutic opportunities for neurodegenerative diseases (review)","volume":"56","author":"Sun","year":"2025","journal-title":"Int J Mol Med"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0137","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"Pt 2","key":"10.1016\/j.trsl.2026.08.005_bib0138","article-title":"MG53\/GMs\/HA-Dex neural scaffold promotes the functional recovery of spinal cord injury by alleviating neuroinflammation","volume":"267","author":"Li","year":"2024","journal-title":"Int J Biol Macromol"},{"issue":"15","key":"10.1016\/j.trsl.2026.08.005_bib0139","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.7150\/ijbs.119301","article-title":"Extracellular matrix dysregulation in aging, calcification, and cancer diseases: insights into cellular senescence, inflammation, and novel therapeutic strategies","volume":"21","author":"Boaru","year":"2025","journal-title":"Int J Biol Sci"},{"issue":"14","key":"10.1016\/j.trsl.2026.08.005_bib0140","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1039\/D2BM00617K","article-title":"In situ microenvironment remodeling using a dual-responsive system: photodegradable hydrogels and gene activation by visible light","volume":"10","author":"Lee","year":"2022","journal-title":"Biomater Sci"},{"issue":"13","key":"10.1016\/j.trsl.2026.08.005_bib0141","doi-asserted-by":"crossref","DOI":"10.3390\/cells14130981","article-title":"Stem-cell niches in health and disease: microenvironmental determinants of regeneration and pathology","volume":"14","author":"Yushkov","year":"2025","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.trsl.2026.08.005_bib0142","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1021\/acsmacrolett.3c00558","article-title":"Cell-membrane coated self-immolative poly(thiourethane) for cysteine\/homocysteine-triggered intracellular H(2)S delivery","volume":"12","author":"Wang","year":"2023","journal-title":"ACS Macro Lett"},{"key":"10.1016\/j.trsl.2026.08.005_bib0143","article-title":"The recent applications of stem cell-derived exosomes and hydrogels in neurological disorders","author":"Ajwad","year":"2025","journal-title":"Tissue Eng Part B Rev"},{"issue":"2","key":"10.1016\/j.trsl.2026.08.005_bib0144","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4103\/NRR.NRR-D-24-00720","article-title":"Exosomes in neurodegenerative diseases: therapeutic potential and modification methods","volume":"21","author":"Chen","year":"2026","journal-title":"Neural Regen Res"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0145","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7150\/thno.117143","article-title":"Engineering exosomes for targeted neurodegenerative therapy: innovations in biogenesis, drug loading, and clinical translation","volume":"16","author":"Huang","year":"2026","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.trsl.2026.08.005_bib0146","doi-asserted-by":"crossref","DOI":"10.3390\/cells13080670","article-title":"Exosomes in vascular\/neurological disorders and the road ahead","volume":"13","author":"Alzahrani","year":"2024","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.trsl.2026.08.005_bib0147","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.4103\/1673-5374.368300","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells alleviate Parkinson's disease and neuronal damage through inhibition of microglia","volume":"18","author":"Zhang","year":"2023","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.trsl.2026.08.005_bib0148","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123014","article-title":"Treatment of Parkinson's disease model with human umbilical cord mesenchymal stem cell-derived exosomes loaded with BDNF","volume":"356","author":"Wang","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.trsl.2026.08.005_bib0149","article-title":"Anti-apoptotic and neurite-protective nanomedicine augments embryonic stem cells-derived retinal ganglion cell transplantation in glaucoma recovery","author":"Chen","year":"2026","journal-title":"Adv Sci"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.005_bib0150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jamaneurol.2015.4321","article-title":"Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1\/2 and 2a clinical trials","volume":"73","author":"Petrou","year":"2016","journal-title":"JAMA Neurol"},{"issue":"24","key":"10.1016\/j.trsl.2026.08.005_bib0151","doi-asserted-by":"crossref","first-page":"e2294","DOI":"10.1212\/WNL.0000000000008620","article-title":"NurOwn, phase 2, randomized, clinical trial in patients with ALS: safety, clinical, and biomarker results","volume":"93","author":"Berry","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.trsl.2026.08.005_bib0152","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/mus.28093","article-title":"Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes","volume":"69","author":"Lindborg","year":"2024","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.005_bib0153","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/mus.27472","article-title":"A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis","volume":"65","author":"Cudkowicz","year":"2022","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.trsl.2026.08.005_bib0154","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/s41591-022-01956-3","article-title":"Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1\/2a trial","volume":"28","author":"Baloh","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0155","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13195-021-00897-2","article-title":"Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase I clinical trial","volume":"13","author":"Kim","year":"2021","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.005_bib0156","doi-asserted-by":"crossref","first-page":"272","DOI":"10.12779\/dnd.2025.24.4.272","article-title":"Mesenchymal stem cells with adjuvant dexamethasone in patients with alzheimer's disease: a phase IIa trial","volume":"24","author":"Lee","year":"2025","journal-title":"Dement Neurocogn Disord"},{"key":"10.1016\/j.trsl.2026.08.005_bib0157","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120156","article-title":"The panoramic view of amyotrophic lateral sclerosis: a fatal intricate neurological disorder","volume":"288","author":"Dhasmana","year":"2022","journal-title":"Life Sci"},{"issue":"8","key":"10.1016\/j.trsl.2026.08.005_bib0158","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41582-024-00991-7","article-title":"Brain-body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis","volume":"20","author":"Jacob","year":"2024","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"10.1016\/j.trsl.2026.08.005_bib0159","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s40263-025-01217-0","article-title":"Genetic and mechanistic insights inform amyotrophic lateral sclerosis treatment and symptomatic management: current and emerging therapeutics and clinical trial design considerations","volume":"39","author":"Quigley","year":"2025","journal-title":"CNS Drugs"},{"key":"10.1016\/j.trsl.2026.08.005_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrrev.2024.108518","article-title":"Unraveling the multifaceted insights into amyotrophic lateral sclerosis: genetic underpinnings, pathogenesis, and therapeutic horizons","volume":"794","author":"Sharma","year":"2024","journal-title":"Mutat Res Rev Mutat Res"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0161","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00793","article-title":"Validation in drosophila of the in silico predicted clomipramine as repurposable for SOD1-ALS","volume":"23","author":"Liguori","year":"2026","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.005_bib0162","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.4103\/NRR.NRR-D-24-01266","article-title":"Latest progress and challenges in drug development for degenerative motor neuron diseases","volume":"21","author":"Wen","year":"2026","journal-title":"Neural Regen Res"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.005_bib0163","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/stcltm\/szad095","article-title":"Optimal therapeutic strategy of bone marrow-originated autologous mesenchymal stromal\/stem cells for ALS","volume":"13","author":"Kim","year":"2024","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"10.1016\/j.trsl.2026.08.005_bib0164","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/stem.1079","article-title":"Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients","volume":"30","author":"Glass","year":"2012","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2021.12.008","article-title":"Human stem cell models of neurodegeneration: from basic science of amyotrophic lateral sclerosis to clinical translation","volume":"29","author":"Giacomelli","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.trsl.2026.08.005_bib0166","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/glia.24516","article-title":"Pyruvate dehydrogenase kinase 2 knockdown restores the ability of amyotrophic lateral sclerosis-linked SOD1G93A rat astrocytes to support motor neuron survival by increasing mitochondrial respiration","volume":"72","author":"Miquel","year":"2024","journal-title":"Glia"},{"key":"10.1016\/j.trsl.2026.08.005_bib0167","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106687","article-title":"TNFalpha prevents FGF4-mediated rescue of astrocyte dysfunction and reactivity in human ALS models","volume":"201","author":"Velasquez","year":"2024","journal-title":"Neurobiol Dis"},{"issue":"7","key":"10.1016\/j.trsl.2026.08.005_bib0168","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.stemcr.2021.05.020","article-title":"Reprogramming astrocytes to motor neurons by activation of endogenous Ngn2 and Isl1","volume":"16","author":"Zhou","year":"2021","journal-title":"Stem Cell Rep"},{"issue":"12","key":"10.1016\/j.trsl.2026.08.005_bib0169","article-title":"Ngn2 and Isl1-mediated astrocyte-to-neuron conversion in vivo promotes functional recovery after spinal cord injury","volume":"6","author":"Zhou","year":"2025","journal-title":"Cell Rep Med"},{"issue":"21","key":"10.1016\/j.trsl.2026.08.005_bib0170","doi-asserted-by":"crossref","DOI":"10.3390\/cells12212565","article-title":"Treating Parkinson's disease with human bone marrow mesenchymal stem cell secretome: a translational investigation using human brain organoids and different routes of in vivo administration","volume":"12","author":"Mendes-Pinheiro","year":"2023","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.trsl.2026.08.005_bib0171","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJM199211263272202","article-title":"Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease","volume":"327","author":"Freed","year":"1992","journal-title":"N Engl J Med"},{"issue":"4942","key":"10.1016\/j.trsl.2026.08.005_bib0172","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1126\/science.2105529","article-title":"Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease","volume":"247","author":"Lindvall","year":"1990","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.trsl.2026.08.005_bib0173","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJM199211263272201","article-title":"Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease","volume":"327","author":"Spencer","year":"1992","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.trsl.2026.08.005_bib0174","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41551-022-00987-y","article-title":"Challenges in the clinical advancement of cell therapies for Parkinson's disease","volume":"7","author":"Skidmore","year":"2023","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0175","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12967-023-04484-x","article-title":"Cell-therapy for Parkinson's disease: a systematic review and meta-analysis","volume":"21","author":"Wang","year":"2023","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.005_bib0176","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.stemcr.2014.01.013","article-title":"Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation","volume":"2","author":"Doi","year":"2014","journal-title":"Stem Cell Rep"},{"issue":"6","key":"10.1016\/j.trsl.2026.08.005_bib0177","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.stem.2025.05.005","article-title":"A new era in regenerative medicine: cell replacement therapy for Parkinson's disease is on the horizon","volume":"32","author":"Cha","year":"2025","journal-title":"Cell Stem Cell"},{"issue":"20","key":"10.1016\/j.trsl.2026.08.005_bib0178","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","article-title":"Personalized iPSC-derived dopamine progenitor cells for Parkinson's disease","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0179","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13287-023-03264-0","article-title":"Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials","volume":"14","author":"Ghasemi","year":"2023","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"10.1016\/j.trsl.2026.08.005_bib0180","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.4103\/1673-5374.387976","article-title":"Effects of mesenchymal stem cell on dopaminergic neurons, motor and memory functions in animal models of Parkinson's disease: a systematic review and meta-analysis","volume":"19","author":"Park","year":"2024","journal-title":"Neural Regen Res"},{"issue":"3","key":"10.1016\/j.trsl.2026.08.005_bib0181","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.03.024","article-title":"Glia-to-neuron conversion by CRISPR-CasRx alleviates symptoms of neurological disease in mice","volume":"181","author":"Zhou","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2026.08.005_bib0182","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75636","article-title":"Repressing PTBP1 fails to convert reactive astrocytes to dopaminergic neurons in a 6-hydroxydopamine mouse model of Parkinson's disease","volume":"11","author":"Chen","year":"2022","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0183","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40035-024-00450-9","article-title":"Controversies and insights into PTBP1-related astrocyte-neuron transdifferentiation: neuronal regeneration strategies for Parkinson's and Alzheimer's disease","volume":"13","author":"Mcdowall","year":"2024","journal-title":"Transl Neurodegener"},{"issue":"21","key":"10.1016\/j.trsl.2026.08.005_bib0184","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.09.005","article-title":"Revisiting astrocyte to neuron conversion with lineage tracing in vivo","volume":"184","author":"Wang","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0185","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41420-024-02176-z","article-title":"Neural stem cells derived from alpha-synuclein-knockdown iPS cells alleviate Parkinson's disease","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.trsl.2026.08.005_bib0186","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102711","article-title":"Cognitive resilience in Alzheimer's disease: mechanism and potential clinical intervention","volume":"106","author":"Jia","year":"2025","journal-title":"Ageing Res Rev"},{"issue":"9","key":"10.1016\/j.trsl.2026.08.005_bib0187","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.1021\/acssensors.5c02453","article-title":"Electrochemical biosensors combined with nanomaterial signal amplification for the detection of Alzheimer's disease biomarkers in blood","volume":"10","author":"Peng","year":"2025","journal-title":"ACS Sens"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0188","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13287-024-03737-w","article-title":"Promoting Alzheimer's disease research and therapy with stem cell technology","volume":"15","author":"Cao","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.trsl.2026.08.005_bib0189","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122852","article-title":"Advanced nano delivery system for stem cell therapy for Alzheimer's disease","volume":"314","author":"Pan","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0190","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1038\/s41467-025-57278-8","article-title":"Serum-tolerant polymeric complex for stem-cell transfection and neural differentiation","volume":"16","author":"Jin","year":"2025","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.trsl.2026.08.005_bib0191","first-page":"1645","article-title":"Mesenchymal stem cell- and extracellular vesicle-based therapies for Alzheimer's disease: progress, advantages, and challenges","volume":"18","author":"Goncalves","year":"2023","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.trsl.2026.08.005_bib0192","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103600","article-title":"Efficient strategy for alleviating neuronal apoptosis and oxidative stress damage of Alzheimer's disease through dual targeting BCL-2 gene promoter i-motif and beta-amyloid","volume":"82","author":"Ji","year":"2025","journal-title":"Redox Biol"},{"issue":"8","key":"10.1016\/j.trsl.2026.08.005_bib0193","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12081628","article-title":"Roles of oxidative stress in synaptic dysfunction and neuronal cell death in Alzheimer's disease","volume":"12","author":"Plascencia-Villa","year":"2023","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.trsl.2026.08.005_bib0194","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41536-023-00311-5","article-title":"Nerve growth factor receptor (Ngfr) induces neurogenic plasticity by suppressing reactive astroglial Lcn2\/Slc22a17 signaling in Alzheimer's disease","volume":"8","author":"Siddiqui","year":"2023","journal-title":"NPJ Regen Med"},{"issue":"12","key":"10.1016\/j.trsl.2026.08.005_bib0195","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202207238","article-title":"Brain-penetrating and disease site-targeting manganese dioxide-polymer-lipid hybrid nanoparticles remodel microenvironment of Alzheimer's disease by regulating multiple pathological pathways","volume":"10","author":"Park","year":"2023","journal-title":"Adv Sci"},{"issue":"8","key":"10.1016\/j.trsl.2026.08.005_bib0196","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1093\/brain\/awab460","article-title":"Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies","volume":"145","author":"Xhima","year":"2022","journal-title":"Brain"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426001714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:55:35Z","timestamp":1790870135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524426001714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":196,"alternative-id":["S1931524426001714"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2026.08.005","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regenerative medicine for neurodegenerative diseases: history, strategies, and clinical advances","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2026.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}